Avalo Therapeutics, Inc. (AVTX)
14.41
-1.51
(-9.48%)
USD |
NASDAQ |
Apr 08, 16:00
15.48
+1.07
(+7.43%)
After-Hours: 20:00
Avalo Therapeutics Profit Margin (Quarterly) : -23.25K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 10.86% |
| Corcept Therapeutics, Inc. | 11.83% |
| Catalyst Pharmaceuticals, Inc. | 34.53% |
| Relmada Therapeutics, Inc. | -- |
| Theravance Biopharma, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -73.16% |
| Return on Assets | -59.41% |
| Return on Invested Capital | -71.38% |
| Gross Profit Margin (Quarterly) | 72.88% |
| Operating Margin (Quarterly) | -33.46K% |
| Return on Net Operating Assets | -694.3% |